Literature DB >> 3491774

Esophagitis in scleroderma. Prevalence and risk factors.

B J Zamost, J Hirschberg, A F Ippoliti, D E Furst, P J Clements, W M Weinstein.   

Abstract

Of 53 patients with scleroderma (43 women and 10 men) evaluated by esophagoscopy and biopsy, 32 (60%) had erosive esophagitis. Symptoms of heartburn and dysphagia were significantly more frequent in the patients who had erosive esophagitis but often were present in those without this condition. Abnormal motility characterized by loss of peristalsis in the distal esophagus was present in all patients with erosive esophagitis, including the 5 who were asymptomatic. No patient with normal esophageal motility had erosive esophagitis at endoscopy. The patients with erosive esophagitis also had significantly diminished lower esophageal sphincter pressures and increased frequency and duration of gastroesophageal reflux episodes. Stricture was present in 13 of 32 patients with erosive esophagitis and was absent in the other 21 patients. The duration of disease, rate of gastric emptying, and fungal smear and culture were not significantly different in those with or without esophagitis. Treatment of fungal infection for a month had little beneficial effect. The pattern of esophageal motility in scleroderma identifies high and low risk groups for esophagitis and stricture, and can be used to select those who require further investigation, irrespective of symptoms.

Entities:  

Mesh:

Year:  1987        PMID: 3491774     DOI: 10.1016/0016-5085(87)90137-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  Intraesophageal pH monitoring during acid infusion in patients with systemic sclerosis.

Authors:  F Carola; P A Bianchi; G Basilisco
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  Relation between esophageal acid exposure and esophageal peristalsis.

Authors:  Joseph C Yarze
Journal:  Dig Dis Sci       Date:  2008-01-19       Impact factor: 3.199

3.  Impedance planimetric characterization of esophagus in systemic sclerosis patients with severe involvement of esophagus.

Authors:  G E Villadsen; J H Storkholm; L Hendel; H Vilstrup; H Gregersen
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

4.  [Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma].

Authors:  T Wehrmann; W F Caspary
Journal:  Klin Wochenschr       Date:  1990-06-19

Review 5.  Classification of oesophageal motility abnormalities.

Authors:  S J Spechler; D O Castell
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

Authors:  J R Murphy; P McNally; P Peller; S S Shay
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 7.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

8.  Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis.

Authors:  M Wegener; R J Adamek; B Wedmann; M Jergas; P Altmeyer
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

9.  Long-term manometry of tubular esophagus in progressive systemic sclerosis.

Authors:  R J Adamek; M Wegener; M Wienbeck; H Köhler; K Hoffmann; P Altmeyer
Journal:  Clin Investig       Date:  1994-05

10.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.